Skip to content
Orbicular Pharmaceutical Technologies logo — Performance, Excellence - Delivered

Orbicular Pharmaceutical Technologies

Performance, Excellence - Delivered

Founded 2010 India India 197 employees Private Equity Total: $20.00M Health Care, Pharmaceutical

General Information

Company Name Orbicular Pharmaceutical Technologies
Founded Year 2010
Location India India
Founders / Decision Makers
Team member
Employees 197
Industries Health Care, Pharmaceutical
Funding Stage Private Equity
Social

BounceWatch is an independent company data service, not affiliated with Orbicular Pharmaceutical Technologies. To contact Orbicular Pharmaceutical Technologies, visit orbicular.co.in.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Orbicular Pharmaceutical Technologies compare?

A PDF of Orbicular Pharmaceutical Technologies and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Orbicular Pharmaceutical Technologies soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Orbicular Pharmaceutical Technologies

Orbicular Pharmaceutical Technologies is a Specialty Pharmaceutical Company based in Hyderabad, India, founded in 2010. The company focuses on developing niche and complex pharmaceutical dosage forms for licensing to global partners. With a 100,000 sq. ft + state-of-the-art Research facility and a team of 300+ competent scientists, the company specializes in generic pharmaceutical product and 505(b)(2) products with complex chemistry, technological barriers, and limited competition for global markets. Their innovative pipeline includes Complex Injectables, Topicals, Ophthalmics, Parenterals, Nasal Sprays/Inhalations, and Complex Peptide combination products targeting various treatment indications. Orbicular Pharmaceutical Technologies' strength lies in its extensive experience in developing cutting edge solutions, proprietary processes, and technologies to deliver products across multiple delivery platforms, including nano-suspensions, nano-emulsions, liposomes, nanoparticles, and long-acting polymeric injectable suspensions. As a result, they are positioned as a one-stop shop ensuring seamless delivery of highly complex products. Their focus on a product domain that is complex, has entry barriers and is lucrative reflects their outcome driven and value generating organization, creating growth partnerships for global pharma players across the entire spectrum of Complex Generics. In conclusion, Orbicular Pharmaceutical Technologies with its strong emphasis on performance excellence signifies a promising player in the pharmaceutical industry, offering potential investment opportunities for venture capitalists seeking innovative solutions in global pharmaceutical markets. To learn more about Orbicular Pharmaceutical Technologies, visit https://orbicular.co.in or reach out to them at [email protected].

Business keywords: Specialty Pharmaceutical Company, Research and Development, Complex Dosage Forms, Global Licensing, Hyderabad, India, Product Delivery, Generic Pharmaceuticals, Complex Chemistry, Cutting Edge Solutions, Niche Pharmaceutical Products, Technology-driven Processes, Complex Generics, Global Pharma Partnerships, Drug Delivery Platforms, Innovative Product Pipeline

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Private Equity Round $20.00M 1
Tata Capital Healthcare Fund
31 May 2024

Orbicular Pharmaceutical Technologies Alternatives & Competitors

View All Alternatives
Orbicular Pharmaceutical Technologies vs

Inventia, established in 1985, is a privately held pharmaceutical development and manufacturing comp...

Private Equity
932 employees
Health Care, Manufacturing
Orbicular Pharmaceutical Technologies vs
Aggrega Pharma, LLC
Aggrega Pharma, LLC United States

A trusted partner in the development and manufacture of niche generic finished dose products for the...

3 employees
Health Care, Pharmaceutical
Orbicular Pharmaceutical Technologies vs

Expressions for a Healthy Life

Post IPO
19366 employees
Health Care, Manufacturing

FAQ About Orbicular Pharmaceutical Technologies

Performance, Excellence - Delivered
Orbicular Pharmaceutical Technologies was founded in 2010.
Orbicular Pharmaceutical Technologies is headquartered in India.
Orbicular Pharmaceutical Technologies operates in Health Care and Pharmaceutical. Its work centres on Specialty Pharmaceutical Company, Research and Development, Complex Dosage Forms and Global Licensing.
Orbicular Pharmaceutical Technologies has approximately 197 employees.
Orbicular Pharmaceutical Technologies has completed 1 funding round, raising a total of $20.00M. The latest funding stage is Private Equity.
Top alternatives and competitors to Orbicular Pharmaceutical Technologies include Inventia Healthcare Limited, Aggrega Pharma, LLC, Intas Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Orbicular Pharmaceutical Technologies and Inventia Healthcare Limited are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Orbicular Pharmaceutical Technologies, https://bouncewatch.com/company/orbicular-pharmaceutical-technologies, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout